Utah’s hottest biotech firm, Recursion Pharmaceuticals, is taking advantage of the red hot stock market as it has announced plans for a $100 million Initial Public Offering.
Recursion Pharma is Going Public
Recursion Pharma is Going Public
Recursion Pharma is Going Public
Utah’s hottest biotech firm, Recursion Pharmaceuticals, is taking advantage of the red hot stock market as it has announced plans for a $100 million Initial Public Offering.